
News|Articles|September 23, 2024
Meeting System Suitability for USP Abacavir and Lamivudine Tablets Assay
Author(s)Phenomenex, Inc.
Abacavir and Lamivudine in combination are used with other medications to treat Human Immunodeficiency Virus (HIV) infection. In this technical note, we report the separation of Lamivudine from its related chiral and diastereomeric impurities in Abacavir and Lamivudine tablets per the USP monograph. The allowable adjustments pertaining to gradient separations are highlighted together with the necessary calculations that are required for the adjusted method conditions to remain compliant with the original monograph.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
HPLC 2025 Revisited: A Year-End Review of LCGC's Conference Coverage Highlights (Part One)
2
A Novel Machine Learning Method for Predicting Retention Time of Small Molecule Pharmaceutical Compounds Across Reversed-phase HPLC Columns
3
Dr. Rigoberto Advincula on Advancing Polymer Research With Py-GC/MS
4
Best of the Week: Career Opportunities for PhD Graduates, Human Expertise and Machine Learning
5